Skip to main content

Table 1 Molecular profiles of patients with perfusion-diffusion mismatch (PDM) and clinical-diffusion mismatch (CDM) who received or did not receive thrombolytic treatment

From: Interleukin-10 facilitates the selection of patients for systemic thrombolysis

  PDM (n = 100) CDM (n = 184)
  NO (n = 21) YES (n = 79) p NO (n = 92) YES (n = 92) p
NSE (ng/mL) 22.4 ± 9.0 20.7 ± 6.1 0.449 24.6 ± 8.3 21.4 ± 5.8 0.002
IL-10 (pg/mL) 8.8 ± 7.0 22.5 ± 14.9 <0.0001 8.6 ± 8.0 30.9 ± 14.7 <0.0001
Glutamate (μM) 150.9 ± 102.2 207.7 ± 177.9 0.290 152.5 ± 91.5 226.6 ± 186.9 0.031
IL-6 (pg/mL) 9.9 ± 8.9 11.9 ± 8.6 0.250 20.9 ± 17.7 14.2 ± 7.6 0.109
TNF-α (pg/mL) 10.3 ± 6.3 11.5 ± 8.2 0.774 12.4 ± 6.6 18.4 ± 12.6 0.003
MMP-9 (ng/mL) 24.0 ± 16.6 21.0 ± 11.9 0.745 29.6 ± 18.4 20.2 ± 8.4 <0.0001